RP-AC 002/2019 May 14, 2019 Subject Clarification of the operating results for the first quarter of 2019 To Directors and Managers of the Stock Exchange of Thailand Richy Place 2002 Public Company

WATTANAPAT HOSPITAL TRANG PUBLIC COMPANY LIMITED No. WPH – SET 8/2019 8 August 2019 Subject : Management Discussion and Analysis for Quarter 2 of 2019 ending on 30 June 2019. To : Directors and

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

-month period ended 30 June 2017 and 2016, net profit of the Company decreased from Baht 74 million to Baht 65 million, decreased by Baht 9 million or 12% due to increase from loss on exchange rate due to

Plastic Public Company Limited and its subsidiaries (“the Company”) would like to clarify herewith the financial position and operating result for the 9-month period ended 30 September 2020 as follows

income surged significantly, especially the 19% increase in bad debt recovery. However, this year the Company will focus on fee-based income expansion. Revenues Structure Profit and Loss Statement Unit

. The shareholder’s equities was decreased to 11.99% due to operation loss for year 2018 of Baht 68.15 million. - As of December 27, 2018, the Company signed a contract to establish a production line and

addition, The Company also incurs the improvement cost in automotive business oversea. 4. Financial cost was decreased by 26.1 million Baht or 107.4%, impacted by the exchange gain/loss on loans in foreign

. Nonetheless, the Company net profit margin on total revenue has decreased from 1.10% to 0.25% compared to the same period of last year. For the first half of year 2018, the Company’s net loss was Bt. 196.12

25 37 (12) -32% Selling expenses 189 291 (102) -35% Administrative expenses 117 145 (28) -20% Profit for the year 352 314 38 12% Profit (loss) attributable to Equity holders of the Company 353 322 31